Rezolute (RZLT) Other Non-Current Assets (2012 - 2026)
Rezolute's (RZLT) quarterly Other Non-Current Assets came in at $2.4 million in Q1 2026, down 16.48% year-on-year from $2.9 million in Q1 2025, and up 1.71% quarter-over-quarter from $2.4 million in Q4 2025.
Rezolute (RZLT) Other Non-Current Assets (2012 - 2026) Analysis & Trends
Rezolute has disclosed Other Non-Current Assets across 14 years of filings, most recently posting $2.4 million for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $2.4 million, down 16.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (down 16.48% YoY), and the FY2025 annual result was $2.9 million, up 59.14% from the prior year.
- Other Non-Current Assets came in at $2.4 million for Q1 2026 at Rezolute, up from $2.4 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $5.0 million in Q1 2022 to a low of $148000.0 in Q2 2022.
- The 5-year median for Other Non-Current Assets is $1.8 million (2024), against an average of $1.7 million.
- Peak annual rise in Other Non-Current Assets reached 41566.67% in 2022, while the deepest fall reached 97.04% in 2022.
- Rezolute's Other Non-Current Assets stood at $148000.0 in 2022, then jumped by 213.51% to $464000.0 in 2023, then soared by 510.34% to $2.8 million in 2024, then declined by 15.18% to $2.4 million in 2025, then grew by 1.71% to $2.4 million in 2026.
- The last three Other Non-Current Assets figures came in at $2.4 million (Q1 2026), $2.4 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.44 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.68 Mn |
| Jun 30, 2025 | 2.93 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | 2.83 Mn |
| Sep 30, 2024 | 1.84 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.84 Mn |
| Dec 31, 2023 | 464,000.00 |
| Sep 30, 2023 | 148,000.00 |
| Jun 30, 2023 | 148,000.00 |
| Mar 31, 2023 | 148,000.00 |
| Dec 31, 2022 | 148,000.00 |
| Sep 30, 2022 | 148,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 5.00 Mn |
| Sep 30, 2021 | 72,000.00 |
| Jun 30, 2021 | 191,000.00 |